Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
6,983,292
-
Share change
-
+451,840
-
Total reported value
-
$12,034,080
-
Price per share
-
$1.73
-
Number of holders
-
25
-
Value change
-
+$768,714
-
Number of buys
-
10
-
Number of sells
-
10
Institutional Holders of CYMABAY THERAPEUTICS INC - COM (CBAY) as of Q4 2016
As of 31 Dec 2016,
CYMABAY THERAPEUTICS INC - COM (CBAY) was held by
25 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,983,292 shares.
The largest 10 holders included
Abingworth LLP, Versant Venture Management, LLC, KINGDON CAPITAL MANAGEMENT, L.L.C., ADAGE CAPITAL PARTNERS GP, L.L.C., Lombard Odier Asset Management (USA) Corp, VANGUARD GROUP INC, J. Goldman & Co LP, BAKER BROS. ADVISORS LP, Omega Fund Management, LLC, and ALLIANCEBERNSTEIN L.P..
This page lists
25
institutional shareholders reporting positions in this security
for the Q4 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.